human
metapneumoviru
hmpv
first
isol
dutch
group
van
den
hoogen
et
al
sinc
viru
detect
contin
nissen
et
al
peret
et
al
stockton
et
al
cueva
et
al
freymuth
et
al
peiri
et
al
fodha
et
al
human
metapneumoviru
singl
human
pathogen
within
genu
metapneumoviru
subfamili
pneumovirina
famili
paramyxovirida
serolog
studi
suggest
viru
circul
human
least
past
year
van
den
hoogen
et
al
ebihara
et
al
mejia
et
al
howev
recent
evid
molecular
studi
suggest
hmpv
may
diverg
avian
metapneumoviru
type
c
earli
year
ago
de
graaf
et
al
yang
et
al
human
metapneumoviru
caus
upper
lower
respiratori
tract
diseas
bronchiol
pneumonia
william
et
al
william
et
al
bouscambertduchamp
et
al
gray
et
al
sarasini
et
al
human
infect
occur
mainli
winter
period
affect
particular
young
children
elderli
peopl
immunocompromis
patient
bastien
et
al
falsey
et
al
shown
serolog
children
year
old
vulner
suscept
contract
viru
van
den
hoogen
et
al
ebihara
et
al
regev
et
al
furthermor
hmpv
detect
respiratori
sampl
revers
transcriptionpcr
rtpcr
mackay
et
al
maertzdorf
et
al
bellaupujol
et
al
realtim
rtpcr
hopkin
et
al
kaida
et
al
addit
sever
monoclon
antibodi
develop
immunofluoresc
assay
ifa
ebihara
et
al
landri
et
al
gerna
et
al
aslanzadeh
et
al
molecular
studi
shown
hmpv
strain
divid
two
major
group
b
minor
group
bastien
et
al
boivin
et
al
paper
describ
studi
concern
hmpv
infect
report
genet
analysi
hmpv
strain
detect
infect
children
three
consecut
winter
normandi
franc
studi
perform
children
admit
univers
hospit
caen
hospit
fler
acut
lower
respiratori
tract
infect
lri
novemb
march
three
consecut
year
novemb
march
patient
underw
nasal
aspir
process
immedi
convent
method
see
remain
sampl
frozen
use
subsequ
molecular
analys
sampl
collect
test
conform
ethic
legisl
place
convent
method
includ
direct
immunofluoresc
assay
dfa
immunofluoresc
assay
use
commerci
avail
monoclon
antibodi
imagen
dako
glostrup
denmark
permit
detect
influenza
viru
type
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
type
adenovirus
dfa
neg
sampl
inocul
onto
cell
line
grown
micropl
describ
previous
briefli
four
day
incub
cell
harvest
use
dfa
antivir
antibodi
cytopath
effect
observ
supernat
relev
well
harvest
use
multiplex
pcr
detect
rhinoviru
enteroviru
human
coronavirus
bellaupujol
et
al
rna
extract
nasal
aspir
qiaamp
viral
rna
minikit
qiagen
hilden
germani
accord
manufactur
instruct
rtpcr
likewis
perform
onestep
rtpcr
kit
qiagen
use
primer
design
gene
forward
primer
revers
primer
provid
pb
pcr
product
thermocycl
condit
min
min
follow
cycl
min
min
min
final
extens
perform
min
result
analyz
agaros
gel
pcr
sensit
group
establish
use
two
fragment
gene
contain
amplif
product
eurofinmwgoperon
ebersberg
germani
repres
respect
consid
like
group
prototyp
sequenc
like
group
b
prototyp
sequenc
synthes
dna
clone
vector
transcript
perform
use
polymeras
appli
biosystemsambion
courtaboeuf
franc
dnase
treatment
appli
biosystem
ambion
rna
concentr
determin
measur
absorb
nm
nanodrop
spectrophotomet
system
serial
dilut
perform
determin
sensit
assay
copi
viral
rna
per
reaction
heminest
pcr
perform
revers
primer
new
forward
primer
amplif
realiz
use
amplitaq
appli
biosystem
foster
citi
ca
follow
program
min
follow
cycl
sec
sec
sec
final
elong
min
pb
product
obtain
first
purifi
enzym
exosapit
amersham
bioscienc
uppsala
sweden
accord
manufactur
instruct
quantifi
spectromet
subsequ
purifi
pcr
product
sequenc
beckman
ceq
tm
genet
analysi
system
ceq
dtc
quick
start
kit
beckman
coulter
brea
ca
sequenc
assembl
analyz
bioedit
clustalw
softwar
phylogen
studi
carri
use
mega
softwar
neighbor
join
method
bootstrap
perform
replic
rate
nucleotid
sequenc
report
studi
submit
genbank
access
number
rtpcr
allow
detect
copi
per
reaction
b
group
respect
method
perform
virusneg
nasal
aspir
frequenc
hmpv
infect
hospit
children
could
assess
first
last
winter
studi
perform
winter
limit
children
year
age
studi
describ
freymuth
et
al
order
compar
hmpv
preval
common
cold
virus
period
novemb
march
studi
exclus
sampl
respect
contain
respiratori
viru
nasal
aspir
test
tabl
human
metapneumoviru
detect
virusneg
specimen
analyz
respect
function
age
case
infect
children
month
month
month
older
month
respect
tabl
ii
winter
virus
scrutin
dfa
test
use
cultur
model
molecular
tool
human
metapneumoviru
fourth
commonli
detect
viru
human
respiratori
syncyti
viru
hrsv
predomin
repres
virusposit
specimen
follow
rhinovirus
influenza
viru
detect
virus
parainfluenza
virus
adenovirus
coronavirus
enterovirus
influenza
b
viru
children
year
old
hmpv
becam
third
frequent
encount
viru
hrsv
rhinovirus
influenza
viru
repres
case
studi
adenovirus
parainfluenza
virus
coronavirus
enterovirus
influenza
b
viru
tabl
clinic
inform
avail
hmpvinfect
children
winter
mean
age
infect
children
month
tabl
ii
malefemal
ratio
equal
children
hospit
day
onset
symptom
frequent
clinic
sign
admiss
rhiniti
cough
respiratori
distress
syndrom
otiti
nineteen
children
present
upper
respiratori
tract
infect
children
lri
final
clinic
diagnosi
bronchiol
case
bronchopneumonia
six
case
acut
exacerb
asthma
three
case
sign
gastroenter
present
hmpvinfect
children
rotaviru
adenoviru
present
nine
case
seven
hmpvinfect
children
requir
oxygen
therapi
winter
hmpv
hrsv
epidem
appear
end
novemb
peak
almost
immedi
week
later
contradistinct
winter
hmpv
hrsv
epidem
appear
data
bracket
concern
children
less
year
old
b
data
obtain
children
less
year
old
data
obtain
children
less
year
old
phylogen
studi
human
metapneumoviru
later
continu
slowli
human
metapneumoviru
seem
constant
presenc
without
obviou
peak
activ
fig
phylogenet
analysi
carri
gene
hmpv
strain
isol
three
consecut
outbreak
fig
hmpv
strain
distribut
two
group
b
four
relev
subgroup
percentag
ident
gene
hmpv
group
b
strain
vari
percentag
genet
similitud
strain
subgroup
strain
subgroup
respect
human
metapneumoviru
strain
differ
group
subgroup
associ
outbreak
fig
howev
often
one
domin
subgroup
epidem
human
metapneumoviru
belong
subgroup
subgroup
predomin
winter
respect
fig
period
two
strain
promin
repres
greater
isol
hmpv
winter
four
subgroup
present
equal
fig
present
studi
report
epidemiolog
clinic
phylogen
studi
hmpv
outbreak
three
consecut
winter
normandi
franc
human
metapneumoviru
infect
assess
nasal
aspir
receiv
laboratori
month
novemb
march
order
perform
comparison
hmpv
rate
common
cold
virus
report
hmpv
infect
season
longer
hrsv
influenza
virus
van
den
hoogen
et
al
esper
et
al
mackay
et
al
number
posit
case
may
underestim
although
shown
previous
hmpv
circul
predominantli
winterspr
period
bastien
et
al
van
den
hoogen
et
al
esper
et
al
william
et
al
pitoiset
et
al
number
percentag
hmpv
detect
virusneg
sampl
epidem
respect
incid
hmpv
infect
report
mani
studi
william
et
al
also
suggest
number
hmpv
infect
variabl
one
winter
anoth
falsey
et
al
mackay
et
al
william
et
al
human
metapneumoviru
fourth
promin
viru
encount
present
studi
becam
third
promin
result
focus
children
year
old
threequart
hmpv
detect
children
year
old
one
third
less
month
old
human
respiratori
syncyti
viru
predomin
viru
observ
increas
preval
children
year
old
influenza
viru
commonli
encount
popul
year
old
unlik
hmpv
isol
virus
influenza
b
virus
show
distinct
preval
children
year
old
year
old
comparison
hrsv
influenza
virus
b
outbreak
hmpv
occur
period
appear
close
relat
hrsv
epidem
profil
fact
hmpv
hrsv
outbreak
show
variat
winter
month
boivin
et
al
esper
et
al
influenza
epidem
profil
might
independ
entiti
correl
hmpv
hrsv
three
winter
influenza
viru
promin
influenza
b
viru
percentag
appreci
describ
europ
paget
et
al
meijer
et
al
neg
sampl
taken
low
percentag
coinfect
report
previous
peiri
et
al
van
den
hoogen
et
al
mullin
et
al
thu
even
strategi
introduc
select
bia
allow
reliabl
evalu
clinic
impact
hmpv
affect
children
unlik
upper
respiratori
tract
infect
human
metapneumoviru
infect
normal
associ
acut
lri
observ
present
studi
previou
report
freymuth
et
al
william
et
al
inde
patient
present
gastroenter
absenc
alter
respiratori
sign
differ
sever
clinic
manifest
observ
infect
group
group
b
cultiv
hmpv
difficult
achiev
start
present
studi
dfa
test
avail
commerci
rtpcr
design
gene
detect
hmpv
equival
sensit
genotyp
gene
appear
suitabl
hmpv
detect
sinc
alreadi
valid
bellaupujol
et
al
chano
et
al
genet
discrimin
determin
van
den
hoogen
et
al
bastien
et
al
carr
et
al
chano
et
al
moreov
gene
seem
good
candid
detect
virus
like
influenza
virus
coronavirus
donofrio
et
al
vabret
et
al
pcr
appear
adapt
hmpv
detect
character
sinc
four
hmpv
cluster
describ
amplifi
success
mackay
et
al
present
studi
four
hmpv
subtyp
term
detect
rtpcr
rate
differ
subgroup
winter
strain
composit
vari
outbreak
strain
circul
franc
describ
four
previou
studi
bouscambertduchamp
et
al
foulongn
et
al
pitoiset
et
al
first
two
studi
report
subtyp
hmpv
foulongn
et
al
detect
four
subtyp
viru
subgroup
predomin
last
studi
pitoiset
et
al
report
phylogen
analysi
carri
strain
isol
year
altern
subgroup
predomin
first
winter
group
preval
subgroup
promin
repartit
also
found
mani
part
world
esper
et
al
mackay
et
al
ludewick
et
al
pitoiset
et
al
two
studi
describ
anoth
pattern
circul
viru
winter
preval
subgroup
note
gerna
et
al
gray
et
al
winter
predomin
group
could
identifi
incid
group
b
approxim
although
number
strain
belong
group
b
nine
eight
respect
subgroup
frequent
identifi
five
strain
cluster
period
itali
winter
subtyp
also
promin
strain
even
strain
present
gerna
et
al
rate
occurr
group
b
confirm
winter
repres
hmpv
detect
includ
one
hmpv
strain
three
winter
period
strain
observ
data
close
relat
propos
mackay
et
al
studi
carri
australia
period
addit
predomin
subgroup
found
viz
rna
fragment
studi
small
bp
mutat
found
gene
allow
us
discrimin
compar
differ
isol
sequenc
analysi
three
epidem
period
show
two
distinct
genet
profil
first
profil
found
winter
seem
compos
two
predomin
strain
show
exactli
sequenc
repres
least
hmpv
detect
increas
two
winter
foremost
strain
belong
subgroup
respect
find
corrobor
previou
observ
mackay
et
al
winter
period
isol
strain
belong
four
subgroup
two
ident
sequenc
found
even
imposs
consid
isol
like
differ
strain
analysi
assess
short
rna
fragment
heterogen
observ
winter
period
might
consid
begin
shift
group
group
b
confirm
data
shift
natur
report
previous
agapov
et
al
mackay
et
al
oliveira
et
al
despit
fact
studi
incomplet
period
studi
novemb
march
rate
hmpv
still
evalu
year
molecular
evolut
virus
analyz
human
metapneumoviru
circul
normandi
rate
equival
describ
previous
bastien
et
al
boivin
et
al
esper
et
al
present
clinic
studi
demonstr
hmpv
respons
lri
major
case
studi
report
hmpv
subgroup
present
franc
incid
year
result
confirm
genet
evolut
hmpv
normandi
switch
group
b
group
note
winter
final
molecular
tool
develop
gene
appear
use
diagnosi
molecular
analysi
sinc
four
subgroup
detect
discrimin
signific
manner
